Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

US Patent 11439666 · Granted Sep 13, 2022

Estimated economic value: $13,065,000

Assignee

Inventors

View full patent text on Google Patents →